par Simon, Philippe 
;Noël, Jean Christophe ;Celotto, Sabrina
Référence Revue médicale de Bruxelles, 39, 5, page (447-449)
Publication Publié, 2018-10-01
;Noël, Jean Christophe ;Celotto, Sabrina Référence Revue médicale de Bruxelles, 39, 5, page (447-449)
Publication Publié, 2018-10-01
Article révisé par les pairs
| Résumé : | The Nonavalent Gardasil 9 arrived on the Belgian market during 2017. It fulfills an important clinical gap: this vaccine provides indeed a protection against HPV induced cancer at least as good as Cervarix with the addition of the protection against HPV 6 and 11 associated genital warts. |
